Market Overview:
The global next generation sequencers market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for DNA sequencing for diagnostics, drug discovery, and other applications. In addition, the growing focus on personalized medicine is also contributing to the growth of this market. The global next generation sequencers market can be segmented on the basis of type into sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, single-molecule real-time (SMRT) sequencing, and other types. The SBS segment is expected to account for the largest share of the global next generation sequencers market in 2018. This segment is expected to grow at a CAGR of 16% during the forecast period from 2018 to 2030.
Product Definition:
A Next Generation Sequencer (NGS) is a type of DNA sequencer that can produce very long sequencing reads. This allows for the assembly of whole genomes, as well as the detection of rare variants. NGS technology is important for many reasons, including its ability to sequence large amounts of DNA in a short amount of time and its low cost.
Sequencing by Synthesis (SBS):
Sequencing by synthesis is a new technology that allows the generation of long reads and has been used to great effect in the analysis of next-generation sequencing data. The technique involves synthesizing an entire genome, followed by amplification and library preparation steps, all in one vessel. This reduces costs considerably as compared to other NGS methods while also eliminating several hands-on days required for each step.
Ion Semiconductor Sequencing:
Ion semiconductor sequencing is a new technology that allows high-throughput sequencing of DNA and RNA. It utilizes an ionic current generated by a single ampere of electricity to separate the charges on the double Helix. The technique is used in next generation sequencers which are used for rapid whole genome sequencing, gene expression profiling, and other related applications.
Application Insights:
On the basis of application, the global next generation sequencers market is segmented into diagnostics, drug discovery, biomolecule detection and identification, personalized medicine and agriculture and animal research. The diagnostics segment dominated the overall market in terms of revenue share in 2017. This can be attributed to an increase in demand for NGS-based genetic tests for cancer diagnosis as well as other diseases such as hemoglobin disorders & metabolic conditions.
The personalized medicine segment is expected to witness lucrative growth over the forecast period owing to its rising adoption across clinical trials & biomarker studies that focus on identifying disease-causing mutations or determining gene function using genome-wide panels. Moreover, increasing R&D investments by private institutions & biopharmaceutical companies are further anticipated to boost product adoption over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of academic and research institutes involved in sequencing projects, increasing investments by companies for next-generation sequencing technologies, and high adoption rate of technologically advanced products. Moreover, growing focus on personalized medicine coupled with government support is expected to further propel growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments as well as private organizations along with increasing prevalence of chronic diseases that require early diagnosis. In addition, an increase in funding from public & private sectors for genomic studies has fueled regional market development opportunities over recent years; this trend is expected continue through 2018 - 2030 periods.
Growth Factors:
- Increasing demand for Next Generation Sequencers in the life sciences sector for research and development purposes.
- Rising number of Next Generation Sequencing platforms and applications being developed for use in clinical diagnostics laboratories.
- Growing demand for Next Generation Sequencers from the pharmaceutical and biotechnology industries to support drug discovery and development initiatives.
- Proliferation of next-generation sequencing data analysis tools that are making it easier to interpret sequence data generated by these instruments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Next Generation Sequencers Market Research Report
By Type
Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Sequencing by Ligation (SBL), Pyrosequencing, Single-Molecule Real-time (SMRT) Sequencing, Other
By Application
Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture and Animal Research, Others
By Companies
Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg), Oxford Nanopore Technologies, Ltd. (U.K.), Otogenetics Corporation (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Next Generation Sequencers Market Report Segments:
The global Next Generation Sequencers market is segmented on the basis of:
Types
Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Sequencing by Ligation (SBL), Pyrosequencing, Single-Molecule Real-time (SMRT) Sequencing, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture and Animal Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Pacific Biosciences of California, Inc. (U.S.)
- Roche Holding AG (Switzerland)
- QIAGEN N. V. (Germany)
- BGI (China)
- Macrogen Inc. (South Korea)
- Eurofins Scientific (Luxembourg)
- Oxford Nanopore Technologies, Ltd. (U.K.)
- Otogenetics Corporation (U.S.)
Highlights of The Next Generation Sequencers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Sequencing by Ligation (SBL)
- Pyrosequencing
- Single-Molecule Real-time (SMRT) Sequencing
- Other
- By Application:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Personalized Medicine
- Agriculture and Animal Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Next Generation Sequencers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Next Generation Sequencers (NGS) are a type of machine learning algorithm that can be used to sequence DNA or RNA. They are more accurate and faster than traditional sequencing methods, which makes them ideal for large-scale genetic sequencing projects.
Some of the key players operating in the next generation sequencers market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg), Oxford Nanopore Technologies, Ltd. (U.K.), Otogenetics Corporation (U.S.).
The next generation sequencers market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Next Generation Sequencers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Next Generation Sequencers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Next Generation Sequencers Market - Supply Chain
4.5. Global Next Generation Sequencers Market Forecast
4.5.1. Next Generation Sequencers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Next Generation Sequencers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Next Generation Sequencers Market Absolute $ Opportunity
5. Global Next Generation Sequencers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Next Generation Sequencers Market Size and Volume Forecast by Type
5.3.1. Sequencing by Synthesis (SBS)
5.3.2. Ion Semiconductor Sequencing
5.3.3. Sequencing by Ligation (SBL)
5.3.4. Pyrosequencing
5.3.5. Single-Molecule Real-time (SMRT) Sequencing
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Next Generation Sequencers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Next Generation Sequencers Market Size and Volume Forecast by Application
6.3.1. Diagnostics
6.3.2. Drug Discovery
6.3.3. Biomarker Discovery
6.3.4. Personalized Medicine
6.3.5. Agriculture and Animal Research
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Next Generation Sequencers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Next Generation Sequencers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Next Generation Sequencers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Next Generation Sequencers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Next Generation Sequencers Demand Share Forecast, 2019-2026
9. North America Next Generation Sequencers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Next Generation Sequencers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Next Generation Sequencers Market Size and Volume Forecast by Application
9.4.1. Diagnostics
9.4.2. Drug Discovery
9.4.3. Biomarker Discovery
9.4.4. Personalized Medicine
9.4.5. Agriculture and Animal Research
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Next Generation Sequencers Market Size and Volume Forecast by Type
9.7.1. Sequencing by Synthesis (SBS)
9.7.2. Ion Semiconductor Sequencing
9.7.3. Sequencing by Ligation (SBL)
9.7.4. Pyrosequencing
9.7.5. Single-Molecule Real-time (SMRT) Sequencing
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Next Generation Sequencers Demand Share Forecast, 2019-2026
10. Latin America Next Generation Sequencers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Next Generation Sequencers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Next Generation Sequencers Market Size and Volume Forecast by Application
10.4.1. Diagnostics
10.4.2. Drug Discovery
10.4.3. Biomarker Discovery
10.4.4. Personalized Medicine
10.4.5. Agriculture and Animal Research
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Next Generation Sequencers Market Size and Volume Forecast by Type
10.7.1. Sequencing by Synthesis (SBS)
10.7.2. Ion Semiconductor Sequencing
10.7.3. Sequencing by Ligation (SBL)
10.7.4. Pyrosequencing
10.7.5. Single-Molecule Real-time (SMRT) Sequencing
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Next Generation Sequencers Demand Share Forecast, 2019-2026
11. Europe Next Generation Sequencers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Next Generation Sequencers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Next Generation Sequencers Market Size and Volume Forecast by Application
11.4.1. Diagnostics
11.4.2. Drug Discovery
11.4.3. Biomarker Discovery
11.4.4. Personalized Medicine
11.4.5. Agriculture and Animal Research
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Next Generation Sequencers Market Size and Volume Forecast by Type
11.7.1. Sequencing by Synthesis (SBS)
11.7.2. Ion Semiconductor Sequencing
11..3. Sequencing by Ligation (SBL)
11.7.4. Pyrosequencing
11.7.5. Single-Molecule Real-time (SMRT) Sequencing
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Next Generation Sequencers Demand Share, 2019-2026
12. Asia Pacific Next Generation Sequencers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Next Generation Sequencers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Next Generation Sequencers Market Size and Volume Forecast by Application
12.4.1. Diagnostics
12.4.2. Drug Discovery
12.4.3. Biomarker Discovery
12.4.4. Personalized Medicine
12.4.5. Agriculture and Animal Research
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Next Generation Sequencers Market Size and Volume Forecast by Type
12.7.1. Sequencing by Synthesis (SBS)
12.7.2. Ion Semiconductor Sequencing
12.7.3. Sequencing by Ligation (SBL)
12.7.4. Pyrosequencing
12.7.5. Single-Molecule Real-time (SMRT) Sequencing
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Next Generation Sequencers Demand Share, 2019-2026
13. Middle East & Africa Next Generation Sequencers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Next Generation Sequencers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Next Generation Sequencers Market Size and Volume Forecast by Application
13.4.1. Diagnostics
13.4.2. Drug Discovery
13.4.3. Biomarker Discovery
13.4.4. Personalized Medicine
13.4.5. Agriculture and Animal Research
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Next Generation Sequencers Market Size and Volume Forecast by Type
13.7.1. Sequencing by Synthesis (SBS)
13.7.2. Ion Semiconductor Sequencing
13.7.3. Sequencing by Ligation (SBL)
13.7.4. Pyrosequencing
13.7.5. Single-Molecule Real-time (SMRT) Sequencing
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Next Generation Sequencers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Next Generation Sequencers Market: Market Share Analysis
14.2. Next Generation Sequencers Distributors and Customers
14.3. Next Generation Sequencers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumina, Inc. (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific, Inc. (U.S.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pacific Biosciences of California, Inc. (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche Holding AG (Switzerland)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. QIAGEN N. V. (Germany)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BGI (China)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Macrogen Inc. (South Korea)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eurofins Scientific (Luxembourg)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Oxford Nanopore Technologies, Ltd. (U.K.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Otogenetics Corporation (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
